慢性肾脏病与透析患者小腿组织钠浓度的钠-23磁共振成像研究
本研究利用钠-23磁共振成像测量健康对照、慢性肾脏病(CKD)3-5期、血液透析(HD)和腹膜透析(PD)患者小腿皮肤、比目鱼肌和胫骨的组织钠浓度,并探索其与临床生物标志物的相关性。结果显示HD和PD患者组织钠浓度高于对照,且估算肾小球滤过率、血清白蛋白和血红蛋白与组织钠浓度呈负相关。
要点
- HD和PD患者皮肤、比目鱼肌和胫骨组织钠浓度高于健康对照。
- HD患者血清白蛋白与比目鱼肌钠浓度呈强负相关(r=-0.81,P<0.01)。
- CKD患者血红蛋白与比目鱼肌和胫骨钠浓度负相关,HD患者血红蛋白与皮肤和胫骨钠浓度负相关。
核心结论
- HD和PD患者经23Na MRI测量的组织钠浓度升高,可能与CKD和透析中的不良代谢效应相关。
研究设计与样本
- 研究纳入10名健康对照、12名CKD 3-5期患者、13名HD患者和10名PD患者,进行小腿质子与23Na MRI,手动分割皮肤、比目鱼肌和胫骨并测量组织钠浓度,同时采集血样分析常规临床生物标志物。
主要发现
- HD和PD患者皮肤、比目鱼肌和胫骨组织钠浓度高于对照。
- HD患者血清白蛋白与比目鱼肌钠浓度呈强负相关(r=-0.81,P<0.01)。
- 在合并的对照-CKD患者中,估算肾小球滤过率与比目鱼肌钠浓度(r=-0.58,P<0.01)和胫骨钠浓度(r=-0.53,P=0.01)呈负相关。
- CKD患者血红蛋白与比目鱼肌钠浓度(r=-0.65,P=0.02)和胫骨钠浓度(r=-0.73,P<0.01)呈负相关。
- HD患者血红蛋白与皮肤钠浓度(r=-0.60,P=0.04)和胫骨钠浓度(r=-0.76,P<0.01)呈负相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sodium-23 magnetic resonance imaging (23Na MRI) allows direct measurement of tissue sodium concentrations. Current knowledge of skin, muscle and bone sodium concentrations in chronic kidney disease (CKD) and renal replacement therapy patients is limited. In this study we measured the tissue sodium concentrations in CKD, hemodialysis (HD) and peritoneal dialysis (PD) patients with 23Na MRI of the lower leg and explored their correlations with established clinical biomarkers. METHODS: Ten healthy controls, 12 CKD Stages 3-5, 13 HD and 10 PD patients underwent proton and 23Na MRI of the leg. The skin, soleus and tibia were segmented manually and tissue sodium concentrations were measured. Plasma and serum samples were collected from each subject and analyzed for routine clinical biomarkers. Tissue sodium concentrations were compared between groups and correlations with blood-based biomarkers were explored. RESULTS: Tissue sodium concentrations in the skin, soleus and tibia were higher in HD and PD patients compared with controls. Serum albumin showed a strong, negative correlation with soleus sodium concentrations in HD patients (r = -0.81, P < 0.01). Estimated glomerular filtration rate showed a negative correlation with tissue sodium concentrations (soleus: r = -0.58, P < 0.01; tibia: r = -0.53, P = 0.01) in merged control-CKD patients. Hemoglobin was negatively correlated with tissue sodium concentrations in CKD (soleus: r = -0.65, P = 0.02; tibia: r = -0.73, P < 0.01) and HD (skin: r = -0.60, P = 0.04; tibia: r = -0.76, P < 0.01). CONCLUSION: Tissue sodium concentrations, measured by 23Na MRI, increase in HD and PD patients and may be associated with adverse metabolic effects in CKD and dialysis.
引用
- Qirjazi E, Salerno FR, Akbari A, et al. Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging. Nephrol Dial Transplant. 2020. PMID: 32252091. doi:10.1093/ndt/gfaa036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。